Drugs.com - Pharma Industry News

GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression

MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased risk for psychiatric adverse events or worsening depressive symptoms...

May 19, 2025 - 18:50
 0
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased risk for psychiatric adverse events or worsening depressive symptoms...
Read More

Tags:

Previous Article

Overwork Tied to Structural Changes in Brains of Health Care Workers

Next Article

Trump’s science adviser calls for return to ‘gold-standard’ research to kickstar...

Related Posts

CVD Mortality Higher in Women Than Men With Immune-Mediated Inflammatory Diseases

CVD Mortality Higher in Women Than Men With Immune-Medi...

May 13, 2025  0

Increases in Incidence Rates of Some Cancers Seen in Early-Onset Age Groups

Increases in Incidence Rates of Some Cancers Seen in Ea...

May 16, 2025  0

Preinjury Mobility Predicts Adults' Recovery After Lower-Extremity Fracture

Preinjury Mobility Predicts Adults' Recovery After Lowe...

May 15, 2025  0